| Literature DB >> 36014024 |
Fernanda Guilherme do Prado1, Maria Giovana Binder Pagnoncelli2, Gilberto Vinícius de Melo Pereira1, Susan Grace Karp1, Carlos Ricardo Soccol1.
Abstract
In the growing search for therapeutic strategies, there is an interest in foods containing natural antioxidants and other bioactive compounds capable of preventing or reversing pathogenic processes associated with metabolic disease. Fermentation has been used as a potent way of improving the properties of soybean and their components. Microbial metabolism is responsible for producing the β-glucosidase enzyme that converts glycosidic isoflavones into aglycones with higher biological activity in fermented soy products, in addition to several end-metabolites associated with human health development, including peptides, phenolic acids, fatty acids, vitamins, flavonoids, minerals, and organic acids. Thus, several products have emerged from soybean fermentation by fungi, bacteria, or a combination of both. This review covers the key biological characteristics of soy and fermented soy products, including natto, miso, tofu, douchi, sufu, cheonggukjang, doenjang, kanjang, meju, tempeh, thua-nao, kinema, hawaijar, and tungrymbai. The inclusion of these foods in the diet has been associated with the reduction of chronic diseases, with potential anticancer, anti-obesity, antidiabetic, anticholesterol, anti-inflammatory, and neuroprotective effects. These biological activities and the recently studied potential of fermented soybean molecules against SARS-CoV-2 are discussed. Finally, a patent landscape is presented to provide the state-of-the-art of the transfer of knowledge from the scientific sphere to the industrial application.Entities:
Keywords: bioactive compounds; daidzein; fermented soybean foods; genistein; oxidative stress
Year: 2022 PMID: 36014024 PMCID: PMC9416513 DOI: 10.3390/microorganisms10081606
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Figure 1Production, productiveness, and total planted area in hectares of soybean in 2019/2020.
Estimated global supply and demand for soybeans in the 2020/2021 harvest (in millions of tons).
| Initial Stock | Production | Export | Import | Animal Consumption | Domestic Consumption | Final Stock |
|---|---|---|---|---|---|---|
| 100.27 | 362.76 | 312.80 | 158.02 | 360.73 | 161.93 | 98.39 |
| −11% | 8% | 4% | 3% | 4% | 5% | −2% |
Figure 2Soybean production and export of largest producers and estimate for imports in the 119 2020/2021 harvest.
Nutritional composition of soybean.
| Components | % Grain | Chemical Composition (% Dry Weight) | |||
|---|---|---|---|---|---|
| Proteins | Lipids | Carbohydrates | Others * | ||
| Husks | 8 | 9 | 1 | 86 | 4.3 |
| Hypocotyls | 2 | 41 | 11 | 43 | 4.4 |
| Cotyledons | 90 | 43 | 23 | 29 | 5.0 |
| Total | 100 | 40 | 20 | 35 | 5.0 |
* Minerals, vitamins, phytates, and isoflavones.
Figure 3Products fermented soy in Asian countries.
Bioactive compounds of different fermented soy products and their health benefits.
| Soybean Products | Bioactive Compounds | Health Benefits | References |
|---|---|---|---|
| Tempeh | Isoflavone aglycone | Antioxidant properties | [ |
| Tempeh | Isoflavone aglycone | Protection of HepG2 cells from oxidative stress | [ |
| Tempeh | Genistein | Immunomodulatory Function | [ |
| Tempeh | Trans-cinnamic acid | Antioxidant properties | [ |
| Chungkookjang | Poly-γ-glutamic acid (γ-PGA) | Prevention of memory loss from Alzheimer’s and cerebral ischemia | [ |
| Chungkookjang | Daidzein | Anti-diabetic property | [ |
| Chungkookjang | Poly-γ-glutamic acid | Anti-obesity effect | [ |
| Chungkookjang | Bacillomycin D and surfactin | Antimicrobial activity | [ |
| Natto | Nattokinase (NK) | Anti-thrombotic and anti-coagulant activities | [ |
| Natto | Vitamin K2 | Reducing osteoporotic fracture risk | [ |
| Natto | Bacillopeptidase F | Anti-thrombotic and blood pressure-lowering | [ |
| Natto | Nattokinase (NK) | Fibrinolytic activity | [ |
| Miso | Isoflavones aglycones | Anti-tumoral activity | [ |
| Miso | Isoflavones aglycones | Protective effects against stroke | [ |
| Miso | Isoflavones aglycones | Sympathetic nerve activity | [ |
| Doenjang | Linoleic acid and Genistein | Antimutagenic active | [ |
| Doenjang | Genistein | Antimutagenic and anticancer activities | [ |
| Doenjang | Genistein | Anti-obesity effects | [ |
| Kinema | Poly-γ-glutamic acid (γ-PGA) | Suppression of post prandial hyperglycemia | [ |
| Kinema | Isoflavones aglycones | Antioxidant properties | [ |
| Kinema | Group B saponins | Prevention of dietary hypercholesterolemia | [ |
| Douchi | β-glucosidase and protease | Antioxidant activity | [ |
| Sufu | Isoflavones aglycones | Enhancement of the physiological function | [ |
Figure 4Number of registered patents for the compounds of interest (a), countries (b), and years (c) of publications.